title: [Primary hepatic lymphoma - favorable outcome with chemotherapy plus rituximab].
abstract: This article describes the case of a patient with a non-Hodgkin primary hepatic lymphoma who was successfully treated with chemotherapy combined with rituximab. Using the Medical Subject Headings the published reports of this rare entity were reviewed.
authors.affiliation: Servicios de Medicina Interna, Hostpial Universitario 12 de Octubre, Madrid, Espana.
authors.forename: I
authors.initials: I
authors.lastname: Serrano-Navarro
authors.forename: J F
authors.initials: JF
authors.lastname: Rodríguez-López
authors.forename: R
authors.initials: R
authors.lastname: Navas-Espejo
authors.forename: M A
authors.initials: MA
authors.lastname: Pérez-Jacoiste
authors.forename: M A
authors.initials: MA
authors.lastname: Martínez-González
authors.forename: C
authors.initials: C
authors.lastname: Grande
authors.forename: S
authors.initials: S
authors.lastname: Prieto
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D011241:Prednisone / Q000008:administration & dosage; D012074:Remission Induction; D000069283:Rituximab; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone